Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of the Tubular Effects of Dapagliflozin Using 1HNMR Spectroscopy
NCT02798757Phase 4Completed
- Sponsor
- University of Ioannina
- Start
- Jun 2016
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in type 2 diabetes mellitus (T2DM), sponsored by University of Ioannina. Started Jun 2016; status: completed.
02
Drugs
dapagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02798757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02798757.